Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens

Author： Pertwee R.G.   Griffin G.   Lainton J.A.H.   Huffman J.W.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.284, Iss.3, 1995-09, pp. : 241-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens

By Pertwee R.G.   Ross R.A.   Craib S.J.   Thomas A.  

European Journal of Pharmacology, Vol. 456, Iss. 1, 2002-12 ,pp. : 99-106

Elsevier

Access to resources Recommend Favorite

The mouse vas deferens: a pharmacological preparation sensitive to nociceptin

By Calo G.   Rizzi A.   Bogoni G.   Neugebauer V.   Salvadori S.   Guerrini R.   Bianchi C.   Regoli D.  

European Journal of Pharmacology, Vol. 311, Iss. 1, 1996-09 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

Further evidence for the presence of cannabinoid CB 1 receptors in mouse vas deferens

By Pertwee R.G.   Joe-Adigwe G.   Hawksworth G.M.  

European Journal of Pharmacology, Vol. 296, Iss. 2, 1996-01 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

By Pertwee R.G.   Griffin G.  

European Journal of Pharmacology, Vol. 272, Iss. 1, 1995-01 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

Existence of dopamine D 1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens - 1. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists

By Furukawa T.   Morishita H.  

European Journal of Pharmacology, Vol. 328, Iss. 2, 1997-09 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite